A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bayer
This study has previously been posted by Conceptus, Inc. After acquiring Conceptus, Inc., Bayer is now the sponsor of the trial.
Age
21–50
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Women experiencing menorrhagia due to benign causes
Women who are relying on the Essure micro-inserts for permanent contraception following a successful Essure Confirmation Test (as applicable to the Post Approval Study)
Women willing to accept the risk of pregnancy while relying on the Essure micro-inserts for prevention of pregnancy following a NovaSure ablation procedure for menorrhagia
You may not be if
Women who previously underwent a fallopian tube sterilization procedure (other than Essure placement)
Women who present with any other medical complaints, conditions or symptoms unrelated to the Essure System and/or subsequent NovaSure EA including, but not limited to:
* Reproductive tract anatomical variants and/or pathology which could make the subject unsuitable for the Essure and/or NovaSure transcervical procedures
Women currently wearing an intrauterine device and unwilling to have it removed before NovaSure
Clareo Health | A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test
